BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24830297)

  • 1. Maternal serum disintegrin and metalloprotease protein-12 in early pregnancy as a potential marker of adverse pregnancy outcomes.
    Yang J; Wu J; Guo F; Wang D; Chen K; Li J; Du L; Yin A
    PLoS One; 2014; 9(5):e97284. PubMed ID: 24830297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome.
    Poon LC; Chelemen T; Granvillano O; Pandeva I; Nicolaides KH
    Obstet Gynecol; 2008 Nov; 112(5):1082-90. PubMed ID: 18978109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of a disintegrin and metalloprotease 12 level in maternal serum during the first trimester with pregnancy outcome].
    Qi H; Bian XM; Jiang YL; Liu SY; Guo Q
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jun; 44(6):401-4. PubMed ID: 19953936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy.
    Spencer K; Cowans NJ
    J Matern Fetal Neonatal Med; 2007 Sep; 20(9):645-50. PubMed ID: 17701664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal serum ADAM12 (A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks.
    Poon LC; Chelemen T; Minekawa R; Frisova V; Nicolaides KH
    Am J Obstet Gynecol; 2009 May; 200(5):508.e1-6. PubMed ID: 19285649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker.
    Tørring N; Ball S; Wright D; Sarkissian G; Guitton M; Darbouret B
    Reprod Biol Endocrinol; 2010 Oct; 8():129. PubMed ID: 21034452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
    Laigaard J; Spencer K; Christiansen M; Cowans NJ; Larsen SO; Pedersen BN; Wewer UM
    Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum ADAM12 in Chinese women undergoing screening for aneuploidy in the first trimester.
    Liao C; Han J; Sahota D; Li DZ; Sun Q; Lin L; Zhou JY; Yang X; Pan M; Huang YN
    J Matern Fetal Neonatal Med; 2010 Nov; 23(11):1305-9. PubMed ID: 20230315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system.
    Cowans NJ; Spencer K
    Prenat Diagn; 2007 Mar; 27(3):264-71. PubMed ID: 17278174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of first-trimester uterine artery Doppler, a-disintegrin and metalloprotease 12, pregnancy-associated plasma protein a, and maternal characteristics in the prediction of preeclampsia.
    Goetzinger KR; Zhong Y; Cahill AG; Odibo L; Macones GA; Odibo AO
    J Ultrasound Med; 2013 Sep; 32(9):1593-600. PubMed ID: 23980220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses.
    Pihl K; Larsen T; Krebs L; Christiansen M
    Prenat Diagn; 2008 Dec; 28(12):1131-5. PubMed ID: 19003798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Second trimester screening for trisomy 21 using ADAM12-S as a maternal serum marker].
    Jiang T; Lv L; Yang B; Sun YJ; Zhang XJ; Sun Y; Xu QJ; Xu ZF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Jun; 29(3):314-8. PubMed ID: 22678798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester prediction of preterm birth using ADAM12, PAPP-A, uterine artery Doppler, and maternal characteristics.
    Goetzinger KR; Cahill AG; Kemna J; Odibo L; Macones GA; Odibo AO
    Prenat Diagn; 2012 Oct; 32(10):1002-7. PubMed ID: 22847849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First trimester maternal serum ADAM12s levels in twin pregnancies.
    Linskens IH; Twisk JW; Blankenstein MA; van Vugt JM
    Prenat Diagn; 2010 Apr; 30(4):352-6. PubMed ID: 20187159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting first trimester pregnancy outcome: derivation of a multiple marker test.
    Senapati S; Sammel MD; Butts SF; Takacs P; Chung K; Barnhart KT
    Fertil Steril; 2016 Dec; 106(7):1725-1732.e3. PubMed ID: 28340932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum ADAM12 levels correlate with PAPP-A levels during the first trimester.
    Valinen Y; Peuhkurinen S; Järvelä IY; Laitinen P; Ryynanen M
    Gynecol Obstet Invest; 2010; 70(1):60-3. PubMed ID: 20197665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAM12 is an effective marker in the second trimester of pregnancy for prenatal screening of Down syndrome.
    Wang M; Lu S; Zhu Y; Li H
    Prenat Diagn; 2010 Jun; 30(6):561-4. PubMed ID: 20509157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second trimester maternal serum ADAM12 levels in Down's syndrome pregnancies.
    Donalson K; Turner S; Wastell H; Cuckle H
    Prenat Diagn; 2008 Oct; 28(10):904-7. PubMed ID: 18785180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal serum ADAM-12 as a potential marker for different adverse pregnancy outcomes.
    Matwejew E; Cowans NJ; Stamatopoulou A; Spencer K; von Kaisenberg CS
    Fetal Diagn Ther; 2010; 27(1):32-9. PubMed ID: 20090292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of early second trimester PAPP-A and ADAM12 in screening for pre-eclampsia.
    Bestwick JP; George LM; Wu T; Morris JK; Wald NJ
    J Med Screen; 2012 Mar; 19(1):51-4. PubMed ID: 22357350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.